Literature DB >> 2456124

Interferon for treatment: the dust settles.

D Galvani1, S D Griffiths, J C Cawley.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2456124      PMCID: PMC2545949          DOI: 10.1136/bmj.296.6636.1554

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  36 in total

1.  Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2.

Authors:  M S Ernstoff; J M Kirkwood
Journal:  Am J Med       Date:  1984-04       Impact factor: 4.965

2.  Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.

Authors:  H E Broxmeyer; L Lu; E Platzer; C Feit; L Juliano; B Y Rubin
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

3.  Alpha interferon for induction of remission in hairy-cell leukemia.

Authors:  J R Quesada; J Reuben; J T Manning; E M Hersh; J U Gutterman
Journal:  N Engl J Med       Date:  1984-01-05       Impact factor: 91.245

4.  Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden.

Authors:  A Ahre; M Björkholm; H Mellstedt; G Brenning; L Engstedt; G Gahrton; H Gyllenhammar; G Holm; B Johansson; M Järnmark
Journal:  Cancer Treat Rep       Date:  1984-11

5.  Interferon and laryngeal papillomatosis. The Iowa experience.

Authors:  B F McCabe; K F Clark
Journal:  Ann Otol Rhinol Laryngol       Date:  1983 Jan-Feb       Impact factor: 1.547

6.  Application of human leucocyte interferon in patients with carcinoma of the uterine cervix.

Authors:  D Ikić; J Krusić; V Kirhmajer; M Knezević; Z Maricić; B Rode; D Jusić; E Soos
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

7.  Differential effect of interferon on DNA synthesis, 2-deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumor promotors.

Authors:  T Sreevalsan; E Rozengurt; J Taylor-Papadimitriou; J Burchell
Journal:  J Cell Physiol       Date:  1980-07       Impact factor: 6.384

8.  Adjuvant interferon treatment of human osteosarcoma.

Authors:  H Strander; T Aparisi; H Blomgren; L A Broström; K Cantell; S Einhorn; S Ingimarsson; U Nilsonne; G Söderberg
Journal:  Recent Results Cancer Res       Date:  1982

9.  Increased levels of interferon-induced (2'--5') oligo-isoadenylate synthetase in mature T-lymphocytes and in differentiated Friend-erythroleukemic cells.

Authors:  A Kimchi
Journal:  J Interferon Res       Date:  1981

10.  A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.

Authors:  S A Sherwin; J A Knost; S Fein; P G Abrams; K A Foon; J J Ochs; C Schoenberger; A E Maluish; R K Oldham
Journal:  JAMA       Date:  1982-11-19       Impact factor: 56.272

View more
  3 in total

Review 1.  Clinical decisions in the management of the cardiomyopathies.

Authors:  J F Goodwin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

2.  Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study.

Authors:  K P Machold; K Neumann; J S Smolen
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

3.  Type I interferon and interferon-stimulated gene expression in oral epithelial cells.

Authors:  D C Brice; E Figgins; F Yu; G Diamond
Journal:  Mol Oral Microbiol       Date:  2019-10-21       Impact factor: 3.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.